Dr. Guancial is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1970 Golf St
Sarasota, FL 34236Phone+1 941-957-1000Fax+1 941-951-2117
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2009 - 2012
Massachusetts General HospitalResidency, Internal Medicine, 2006 - 2009
Harvard Medical SchoolClass of 2006
Certifications & Licensure
FL State Medical License 2018 - 2026
NY State Medical License 2012 - 2019
MA State Medical License 2008 - 2013- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
Clinical Trials
- Phase 2 Study of Docetaxel +/- OGX-427 in Patients With Relapsed or Refractory Metastatic Bladder Cancer Start of enrollment: 2013 Apr 01
- A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma Start of enrollment: 2019 Dec 18
Roles: Contact
Publications & Presentations
PubMed
- Frontline immune checkpoint inhibitors in patients ≥ 90 years with advanced urothelial cancer: a single center experience.Evangelia Vlachou, Burles Avner Johnson Ⅲ, Elizabeth Guancial, Kara A Lombardo, Jean Hoffman-Censits
The Canadian Journal of Urology. 2024-06-01 - 333 citationsPembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, ...Thomas Powles, Tibor Csőszi, Mustafa Ozguroglu, Nobuaki Matsubara, Lajos Géczi
The Lancet. Oncology. 2021-07-01 - 6 citationsThe Role of Metastasectomy in Urothelial Carcinoma: Where Are We in 2020?Emily Lemke, Deepak M. Sahasrabudhe, Elizabeth A. Guancial, Kathryn A. Bylow, Scott Johnson
Clinical Genitourinary Cancer. 2020-01-27
Press Mentions
Cancer Treatment Practices Hires New OncologistAugust 1st, 2018
Urothelial Carcinoma Drug Shortages: Insights From ASCO GUFebruary 6th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
